protein phosphatase 1, regulatory (inhibitor) subunit 14A
RGD ID:
620536
Description:
Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in regulation of phosphorylation. Predicted to act upstream of or within cellular response to xenobiotic stimulus. Predicted to be located in cytoplasm. Orthologous to human PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A); INTERACTS WITH (R)-noradrenaline; 17alpha-ethynylestradiol; 17beta-estradiol.
17 kDa PKC-potentiated inhibitory protein of PP1; CPI-17; Cpi17; protein kinase C-potentiated inhibitor protein of 17 kDa; protein phosphatase 1 regulatory subunit 14A
Beclomethasone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] and Prednisolone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R14A mRNA
[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PPP1R14A mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PPP1R14A mRNA
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R14A protein]] more ...
geranylgeraniol inhibits the reaction [Simvastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of PPP1R14A protein]] more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R14A mRNA